Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

1 Company Gilead Sciences Should Consider Buying Right Now
Motley Fool
Sat, 02/6/16 - 12:28 pm
Tags:
Gilead Sciences, M&A, hepatitis C, Intercept Pharma
Gilead Sciences: Why Slowing Hep-C Sales Don’t Matter
Barron's
Fri, 02/5/16 - 09:40 pm
Tags:
Gilead Sciences, hepatitis C
Blockbuster new launches coming from Intercept, Gilead and Merck: Reuters
Fierce Pharma
Fri, 02/5/16 - 09:51 am
Tags:
drug launches, Intercept Pharma, Gilead Sciences, Merck
Seven $1 billion-plus drugs seen reaching market in 2016
Yahoo/Reuters
Thu, 02/4/16 - 09:29 am
Tags:
Intercept Pharmaceuticals, Gilead Sciences, Roche, AbbVie, Merck, obeticholic acid, emtricitabine
Gilead: Reading the Biotech M&A Tea Leaves
WSJ Online
Wed, 02/3/16 - 08:44 am
Tags:
Gilead Sciences, biotech, M&A
Gilead's hep C juggernaut continues in Q4, even as U.S. sales fall
Fierce Pharma
Wed, 02/3/16 - 08:27 am
Tags:
earnings, Gilead Sciences
Will Gilead Follow The Pfizer Game Plan For Sales Growth?
Forbes
Tue, 02/2/16 - 10:27 am
Tags:
Gilead Sciences, Pfizer
Gilead accused of manipulating HIV patents
Stat
Mon, 02/1/16 - 11:23 pm
Tags:
Gilead Sciences, patients, HIV, tenofovir
Can Gilead's Earnings Inject Stock Growth? (GILD) By Richard Saintvilus | February 01, 2016
Investopedia
Mon, 02/1/16 - 11:12 pm
Tags:
Gilead Sciences, earnings
Merck Takes on Gilead With Sharply Lower Hepatitis C Drug Price
TheStreet.com
Fri, 01/29/16 - 10:34 am
Tags:
Merck, Gilead Sciences, hepatitis C, Zepatier, drug pricing
Gilead CEO Martin to Step Down, Will Be Replaced by COO
Bloomberg
Fri, 01/29/16 - 10:21 am
Tags:
Gilead Sciences, John Martin, John Milligan, Pharma CEOs
3 Things to Watch in Gilead Sciences' Q4 Results
Motley Fool
Thu, 01/28/16 - 09:04 pm
Tags:
Gilead Sciences, earnings
Gilead Takes a Page Out of Celgene's Playbook
Motley Fool
Sat, 01/23/16 - 12:51 pm
Tags:
Gilead Sciences, Celgene, Galapagos, M&A, filgotinib
Yes, Gilead put superhigh prices on hep C drugs, but what can you do? Senators ask
Fierce Pharma
Sat, 01/23/16 - 11:07 am
Tags:
Gilead Sciences, drug pricing, hepatitis C
How Big a Threat is Eli Lilly to Gilead Sciences?
Bidness, ETC
Wed, 01/20/16 - 08:40 am
Tags:
Eli Lilly, Gilead Sciences, baricitinib, JAK inhibitors
The Top Biotech Stocks of 2016
Investopedia
Tue, 01/19/16 - 09:23 am
Tags:
biotech, Amgen, Gilead Sciences, Biogen
A Pre-Earnings Discussion Of Breaking News On Gilead; More Positives Than Negatives
Seeking Alpha
Wed, 01/13/16 - 03:53 pm
Tags:
Gilead Sciences, earnings
3 Slides Suggesting Gilead Sciences May Be Unstoppable
Motley Fool
Tue, 01/12/16 - 02:41 pm
Tags:
Gilead Sciences, HIV, hepatitis C, oncology
4 Pharmaceutical Stocks With Big Catalysts Pending in 2016
24/7 Wall St
Fri, 01/8/16 - 09:43 am
Tags:
Jazz Pharmaceuticals, Defibrotide, Clovis Oncology, rociletinib, Insys, Dronabinol, Gilead Sciences, F/TAF
Why Gilead Is 'The Apple Of Biotech'
Yahoo/Benzinga
Fri, 01/8/16 - 09:32 am
Tags:
Gilead Sciences, hepatitis C, Apple

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.